DK1482967T3 - Farmaceutiske og kosmetiske sammensætninger omfattende plgf-1 - Google Patents

Farmaceutiske og kosmetiske sammensætninger omfattende plgf-1

Info

Publication number
DK1482967T3
DK1482967T3 DK03712652.1T DK03712652T DK1482967T3 DK 1482967 T3 DK1482967 T3 DK 1482967T3 DK 03712652 T DK03712652 T DK 03712652T DK 1482967 T3 DK1482967 T3 DK 1482967T3
Authority
DK
Denmark
Prior art keywords
plgf
pharmaceutical
cosmetic compositions
comprehensive
compositions comprehensive
Prior art date
Application number
DK03712652.1T
Other languages
English (en)
Inventor
Domenico Maglione
Mauro Battisti
Ettore Conti
Giuseppe Salvia
Marina Tucci
Original Assignee
Geymonat Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11456138&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1482967(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Geymonat Spa filed Critical Geymonat Spa
Application granted granted Critical
Publication of DK1482967T3 publication Critical patent/DK1482967T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A61K38/1866—Vascular endothelial growth factor [VEGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Vascular Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK03712652.1T 2002-03-05 2003-03-05 Farmaceutiske og kosmetiske sammensætninger omfattende plgf-1 DK1482967T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2002RM000119A ITRM20020119A1 (it) 2002-03-05 2002-03-05 Composizioni contenenti plgf ad uso farmaceutico e cosmetico.
PCT/IT2003/000132 WO2003074075A1 (en) 2002-03-05 2003-03-05 Pharmaceutical and cosmetic compositions comprising plgf-1

Publications (1)

Publication Number Publication Date
DK1482967T3 true DK1482967T3 (da) 2013-08-26

Family

ID=11456138

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03712652.1T DK1482967T3 (da) 2002-03-05 2003-03-05 Farmaceutiske og kosmetiske sammensætninger omfattende plgf-1

Country Status (20)

Country Link
US (1) US7364722B2 (da)
EP (1) EP1482967B1 (da)
JP (2) JP5010093B2 (da)
KR (1) KR100988656B1 (da)
CN (1) CN100467058C (da)
AU (1) AU2003217464B2 (da)
BR (1) BR0308040A (da)
CA (1) CA2477075C (da)
CY (1) CY1114209T1 (da)
DK (1) DK1482967T3 (da)
ES (1) ES2424827T3 (da)
HR (1) HRP20040914A2 (da)
IT (1) ITRM20020119A1 (da)
MX (1) MXPA04008486A (da)
PL (1) PL371788A1 (da)
PT (1) PT1482967E (da)
RU (1) RU2292906C2 (da)
SI (1) SI1482967T1 (da)
WO (1) WO2003074075A1 (da)
ZA (1) ZA200407707B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2872040B1 (fr) * 2004-06-23 2006-09-22 Centre Nat Rech Scient Cnrse Utilisation cosmetique d'au moins un tetrapeptide naturel ac-n-ser-asp-lys-pro- ou un de ses analogues en tant qu'agent antivieillissement et restructurant de la peau
US8057458B2 (en) * 2006-10-30 2011-11-15 Warsaw Orthopedic, Inc. Method for treating facet pain
BRPI1008815A2 (pt) * 2009-02-05 2018-02-14 Digna Biotech, S.L composições farmacêuticas compreendendo peptídeos inibidores de tgf-beta1
US8741850B2 (en) 2009-07-24 2014-06-03 Advanced Accelerator Applications S.A. Compounds modulators of VEGF activity and uses thereof
US10729746B2 (en) 2013-01-28 2020-08-04 Shire Human Genetic Therapies, Inc. Recombinant placenta growth factor for treating Duchenne muscular dystrophy
EP3094336A4 (en) 2014-01-17 2018-02-14 MIMEDX Group Inc. Method for inducing angiogenesis

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1283892A (en) * 1970-06-08 1972-08-02 Irwin Irville Lubowe Improvements in and relating to medicinal compositions for application to the skin and/or hair
IT1242149B (it) 1990-09-27 1994-02-16 Consiglio Nazionale Ricerche Sequenza di nucleotidi codificante per una proteina umana con proprieta' regolative dell'angiogenesi
EP0845992B1 (en) * 1995-08-15 2002-11-20 Connetics Corporation Use of relaxin for promoting angiogenesis
RU2102091C1 (ru) * 1995-09-19 1998-01-20 Казанский медицинский университет Способ лечения системной склеродермии
WO1997048405A1 (fr) * 1996-06-21 1997-12-24 Jury Evgenievich Belyaev Produit semi-fini permettant d'obtenir des bases de medicaments, bases de medicaments obtenues a l'aide ce dernier et variantes, et medicament faisant appel a ces bases et variantes
CN1345247A (zh) * 1997-12-24 2002-04-17 路德维格癌症研究所 表达血管内皮生长因子d的表达载体和细胞系以及治疗黑素瘤的方法
WO2001000792A1 (en) * 1999-06-29 2001-01-04 Marchosky J Alexander Compositions and methods for forming and strengthening bone
JP3877914B2 (ja) * 1999-09-07 2007-02-07 サンスター株式会社 皮膚化粧料
AU4643501A (en) * 2000-02-04 2001-08-14 Flanders Interuniversity Institute For Biotechnology (Vib) Use of vascular endothelial growth factor, placenta growth factor or both for preventing or treating ischemic diseases or stroke
JP2001316242A (ja) * 2000-03-02 2001-11-13 Noevir Co Ltd 皮膚外用剤
US6773881B2 (en) * 2000-03-31 2004-08-10 The General Hospital Corporation Methods of modulating hair growth

Also Published As

Publication number Publication date
ITRM20020119A1 (it) 2003-09-05
AU2003217464A1 (en) 2003-09-16
RU2004129586A (ru) 2005-06-10
HRP20040914A2 (en) 2004-12-31
HK1078469A1 (zh) 2006-03-17
US20050239698A2 (en) 2005-10-27
KR20040111379A (ko) 2004-12-31
SI1482967T1 (sl) 2013-10-30
US7364722B2 (en) 2008-04-29
ITRM20020119A0 (it) 2002-03-05
JP5144690B2 (ja) 2013-02-13
AU2003217464B2 (en) 2007-08-30
CA2477075C (en) 2013-08-06
US20050075288A1 (en) 2005-04-07
JP5010093B2 (ja) 2012-08-29
EP1482967B1 (en) 2013-05-15
CY1114209T1 (el) 2016-08-31
CN1638793A (zh) 2005-07-13
BR0308040A (pt) 2004-12-14
JP2010116405A (ja) 2010-05-27
ZA200407707B (en) 2005-07-27
MXPA04008486A (es) 2005-04-19
CN100467058C (zh) 2009-03-11
PL371788A1 (en) 2005-06-27
KR100988656B1 (ko) 2010-10-18
ES2424827T3 (es) 2013-10-08
EP1482967A1 (en) 2004-12-08
PT1482967E (pt) 2013-08-27
RU2292906C2 (ru) 2007-02-10
CA2477075A1 (en) 2003-09-12
JP2005519101A (ja) 2005-06-30
WO2003074075A1 (en) 2003-09-12

Similar Documents

Publication Publication Date Title
IS2504B (is) Fosfónóoxýkínasólínafleiður og lyfjafræileg notkun þeirra
DK1713544T3 (da) Sammensætninger og fremgangsmåder til oral og personlig pleje
DE60317699D1 (de) Fermentationsverfahren und -zusammensetzungen
FR2842417B1 (fr) Composition cosmetique
FR2842416B1 (fr) Composition cosmetique
KR20050009999A (ko) 약제학적 제제
IS3007B (is) Ónæmisbælandi efnasambönd og efnablöndur
NO20044192L (no) 17alfa-alkyl-17beta-oksy-ostratriener og farmasoytiske preparater
NO20052524D0 (no) Aminerte isofiavonoidderivater og anvendelse derav
IL173726A (en) Pharmaceutical compositions containing n-n-dihaloamino acids and their uses
DK1354873T3 (da) Perindoaprilsalt og farmaceutiske sammensætninger indeholdende dette
PT1558595E (pt) Piperazinil e diazepanil benzamidas e benzotioamidas
IL163868A (en) Hemiasterlin derivatives and pharmaceutical compositions comprising them
EP1565205A4 (en) Interferon-alpha polypeptides and conjugates
DK1663291T3 (da) Rekombinante lubricinmolekyler og anvendelser deraf
IL170313A (en) Diarylcycloalkyl derivatives and pharmaceutical compositions comprising them
GB0212749D0 (en) Personal care compositions
DK1589938T3 (da) Mundplejesammensætninger og fremgangsmåder hertil
DK1849468T3 (da) Farmaceutisk sammensætning omfattende roflumilast og levocetirizin
NO20030156L (no) Farmasöytiske sammensetninger og fremgangsmåter for anvendelse derav
DK1482967T3 (da) Farmaceutiske og kosmetiske sammensætninger omfattende plgf-1
GB2384705B (en) Cosmetic and related compositions
DK1680134T3 (da) Sammensætninger og anvendelser deraf
AU2003258772A8 (en) Novel neutracetical and pharmaceutical compositions and their uses
NO20044164L (no) Farmasoytiske sammensetninger